Volume 143, Issue 1, January 2020

Editorial

James Rowe
Brain, Volume 143, Issue 1, January 2020, Page 1, https://doi.org/10.1093/brain/awz395

Scientific Commentaries

Niko Hensel and others
Brain, Volume 143, Issue 1, January 2020, Pages 2–5, https://doi.org/10.1093/brain/awz394

This scientific commentary refers to ‘ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy’, by Kannan et al. (doi: 10.1093/brain/awz373).

Ana Westenberger and Christine Klein
Brain, Volume 143, Issue 1, January 2020, Pages 5–8, https://doi.org/10.1093/brain/awz404

This scientific commentary refers to ‘Expansion of GGC repeat in human-specific NOTCH2NLC gene is associated with essential tremor’ by Sun et al. (doi: 10.1093/brain/awz372).

Melinda C Power
Brain, Volume 143, Issue 1, January 2020, Pages 8–10, https://doi.org/10.1093/brain/awz396

This scientific commentary refers to ‘Particulate matter and episodic memory decline mediated by early neuroanatomic biomarkers of Alzheimer’s disease’, by Younan et al. (doi: 10.1093/brain/awz348).

Michael Schöll and Anne Maass
Brain, Volume 143, Issue 1, January 2020, Pages 10–13, https://doi.org/10.1093/brain/awz399

This scientific commentary refers to ‘Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age’, by Betthauser et al. (doi: 10.1093/brain/awz378).

Review Articles

Daniel Weiss and others
Brain, Volume 143, Issue 1, January 2020, Pages 14–30, https://doi.org/10.1093/brain/awz314

Freezing of gait is disabling and difficult to treat. Weiss et al. review recent advances in clinical phenomenology, genetics, multimodal imaging, neurophysiology and neuromodulation, and synthesize the findings into an overarching perspective linking these domains. Finally, they propose topics for future research to obtain further insights and to devise new therapeutic approaches.

Elie Matar and others
Brain, Volume 143, Issue 1, January 2020, Pages 31–46, https://doi.org/10.1093/brain/awz311

Fluctuating cognition is perhaps the most enigmatic and least understood of the core features of Lewy body dementia. Matar et al. review the phenomenology, neuropsychological, physiological and imaging correlates of fluctuations, and then integrate them into a testable heuristic framework from which new insights can be gained.

Report

Cameron P Casey and others
Brain, Volume 143, Issue 1, January 2020, Pages 47–54, https://doi.org/10.1093/brain/awz354

Is there a causal relationship between delirium and cognitive decline? Casey et al. show that postoperative delirium is associated with an increase in plasma levels of neurofilament light, a neuronal injury biomarker. Levels of neurofilament light correlate with peak delirium severity, suggesting that neuronal injury contributes to delirium pathogenesis.

Original Articles

Christopher C Y Mak and others
Brain, Volume 143, Issue 1, January 2020, Pages 55–68, https://doi.org/10.1093/brain/awz379

Rhombencephalosynapsis is a rare cerebellar malformation of unknown cause. Mak et al. report the identification of a cluster of de novo truncating mutations in the MN1 gene in patients with a novel syndrome that comprises midface hypoplasia, severe language delay and distinctive brain malformations including an atypical form of rhombencephalosynapsis.

Annapoorna Kannan and others
Brain, Volume 143, Issue 1, January 2020, Pages 69–93, https://doi.org/10.1093/brain/awz373

See Hensel et al. (doi:10.1093/brain/awz394) for a scientific commentary on this article.

In spinal muscular atrophy (SMA), chronic low levels of SMN lead to neurodegeneration via accumulation of R-loops and DNA damage. Kannan, Jiang et al. show that overexpression of ZPR1 prevents R-loops and rescues DNA damage in SMA mice and patient cells. ZPR1 enhances SMN2 expression and rescues the SMA phenotype.

Christina R Fagerberg and others
Brain, Volume 143, Issue 1, January 2020, Pages 94–111, https://doi.org/10.1093/brain/awz376

Fagerberg et al. describe a novel childhood-onset neurometabolic disease caused by choline transporter deficiency with autosomal recessive inheritance. They identify three separate causative mutations in SLC44A1, and show that impaired transport of choline for membrane phospholipid biosynthesis is a critical mechanism in disease pathogenesis.

Nicole J Van Bergen and others
Brain, Volume 143, Issue 1, January 2020, Pages 112–130, https://doi.org/10.1093/brain/awz374

Van Bergen et al. add to the growing number of ‘trappopathies’ by identifying a pathogenic variant in TRAPPC4 in seven children with early-onset seizures and developmental delay. The incompletely penetrant splicing defect reduces protein levels and TRAPP complex assembly, and impairs vesicular trafficking and autophagy in patient cells and yeast.

Anika Bongaarts and others
Brain, Volume 143, Issue 1, January 2020, Pages 131–149, https://doi.org/10.1093/brain/awz370

Subependymal giant cell astrocytomas (SEGAs) cause serious neurological complications in patients with tuberous sclerosis complex. Using high-throughput sequencing, Bongaarts et al. identify MAPK/ERK activation in SEGAs, potentially via the "Ragulator complex", and propose that the MAPK/ERK pathway could be a novel treatment target.

Kim A Meijer and others
Brain, Volume 143, Issue 1, January 2020, Pages 150–160, https://doi.org/10.1093/brain/awz355

The severity and effects of damage to short- and long-range structural connections in multiple sclerosis are unknown. Meijer et al. report that long-range connections are more severely damaged than short-range connections. Damage to long-range connections is more strongly associated with reduced structural network efficiency, abnormal functional connectivity, and impaired cognition.

Qing-Long Miao and others
Brain, Volume 143, Issue 1, January 2020, Pages 161–174, https://doi.org/10.1093/brain/awz365

Inborn errors of CACNA1A-encoded P/Q-type calcium channels give rise to childhood absence epilepsy, ataxia and dystonia. Miao et al. show that adult-onset ablation of the P/Q channel alpha subunit in mice replicates the inborn loss-of-function phenotype, and that distinct thalamic bursting mechanisms can generate similar patterns of cortical hypersynchrony.

Xiaosong He and others
Brain, Volume 143, Issue 1, January 2020, Pages 175–190, https://doi.org/10.1093/brain/awz361

The absence of a blueprint for the interactive pathways underlying secondary seizure generalization has hindered epilepsy management. He et al. reveal how focal to bilateral tonic-clonic seizures reshape the brain, promoting thalamus-mediated cortico-cortical communication and reducing basal ganglia–thalamus interactions through the direct basal ganglia pathway.

Sarah Gourmaud and others
Brain, Volume 143, Issue 1, January 2020, Pages 191–209, https://doi.org/10.1093/brain/awz381
Eric L Harshfield and others
Brain, Volume 143, Issue 1, January 2020, Pages 210–221, https://doi.org/10.1093/brain/awz362

Whether haematological traits contribute equally to all ischaemic stroke subtypes is unclear. By analysing summary statistics from genome-wide association studies of haematological traits and MEGASTROKE, Harshfield et al. show that genetically altered levels of several coagulation factors are associated with ischaemic, cardioembolic, and large-artery stroke, but not small-vessel stroke.

Qi-Ying Sun and others
Brain, Volume 143, Issue 1, January 2020, Pages 222–233, https://doi.org/10.1093/brain/awz372

See Westenberger and Klein (doi:10.1093/brain/awz404) for a scientific commentary on this article.

Sun et al. identify an abnormal GGC repeat expansion in the 5’ region of NOTCH2NLC in 11 families from a cohort of Chinese pedigrees with essential tremor. The results provide strong evidence that essential tremor is a family of diseases with high clinical and genetic heterogeneity.

Cornelis Blauwendraat and others
Brain, Volume 143, Issue 1, January 2020, Pages 234–248, https://doi.org/10.1093/brain/awz350

Variation in GBA confers a spectrum of increased risk for Parkinson’s disease. Blauwendraat et al. report that an individual’s overall Parkinson’s disease genetic risk score modifies the effect of GBA variants on disease risk and age at onset. Genes implicated in lysosomal function exert the most influence on GBA-associated risk.

Tomoyuki Taguchi and others
Brain, Volume 143, Issue 1, January 2020, Pages 249–265, https://doi.org/10.1093/brain/awz380

Taguchi, Ikuno et al. develop a transgenic mouse model of prodromal Parkinson’s disease that expresses mutant human alpha-synuclein from a bacterial artificial chromosome. The mice show hyposmia as well as REM sleep without atonia. By providing insights into early pathogenesis, the model should aid the development of disease-modifying therapies.

Joshua D Crapser and others
Brain, Volume 143, Issue 1, January 2020, Pages 266–288, https://doi.org/10.1093/brain/awz363

Microglia are activated in Huntington’s disease prior to symptom onset. Crapser et al. show that eliminating microglia from the R6/2 mouse model of Huntington’s disease reduces motor and cognitive impairments, accumulation of mutant huntingtin, and striatal volume loss. It also prevents the loss of perineuronal nets.

Diana Younan and others
Brain, Volume 143, Issue 1, January 2020, Pages 289–302, https://doi.org/10.1093/brain/awz348

See Power (doi:10.1093/brain/awz396) for a scientific commentary on this article.

How does exposure to air pollution increase dementia risk? In a longitudinal study of cognitively intact elderly, Younan et al. find that greater exposure to fine particulate matter is associated with faster decline in immediate recall/new learning, partly mediated by grey matter atrophy in areas vulnerable to Alzheimer’s disease pathology.

Vincent Huin and others
Brain, Volume 143, Issue 1, January 2020, Pages 303–319, https://doi.org/10.1093/brain/awz377

Homozygous GRN mutations produce neuronal ceroid lipofuscinosis-11, a rare lysosomal storage disorder. Huin et al. expand the phenotypic spectrum of homozygous mutations to include late-onset frontotemporal dementia. They demonstrate that some GRN mutations are hypomorphic, and reveal lysosomal dysfunction in the brains of homozygous patients, thus providing new insights into GRN disease mechanisms.

Tobey J Betthauser and others
Brain, Volume 143, Issue 1, January 2020, Pages 320–335, https://doi.org/10.1093/brain/awz378

See Schöll and Maass (doi:10.1093/brain/awz399) for a scientific commentary on this article.

Betthauser et al. present the results of a retrospective analysis of cognitive trajectories in initially unimpaired adults stratified according to PET amyloid and tau status. Individuals with elevated levels of both pathophysiological beta-amyloid and tau show faster cognitive decline during late middle-age than those with one or no elevated biomarkers.

Differences in cognitive performance over time were investigated between neuroimaging biomarker groups for beta-amyloid and tau in initially cognitively unimpaired persons. The combination of pathologic beta-amyloid and tau was detrimental to cognitive decline in preclinical AD during late middle-age. Middle-age health factors likely do not influence AD-related preclinical cognitive decline.

Maya Koronyo-Hamaoui and others
Brain, Volume 143, Issue 1, January 2020, Pages 336–358, https://doi.org/10.1093/brain/awz364

Angiotensin-converting enzyme (ACE) can degrade Aβ. Koronyo-Hamaoui et al. show that administration of ACE-overexpressing macrophages, by bone marrow transplantation or monocyte blood enrichment, preserves vascular integrity and cognition while enhancing resistance to Aβ in Alzheimer’s disease-model mice. Immunotherapy with peripheral monocytes overexpressing ACE has the potential to fight Alzheimer’s disease.

Christopher D Morrone and others
Brain, Volume 143, Issue 1, January 2020, Pages 359–373, https://doi.org/10.1093/brain/awz371

Aβ clearance does not improve cognition in patients with Alzheimer’s disease. Using a transgenic rat model, Morrone et al. show that Aβ attenuation has no effect on entorhinal tau or entorhinal-hippocampal network dysfunction, explaining the persistence of spatial memory deficits. However, it improves hippocampal function, thereby rescuing pattern separation and executive function.

Dorsal Column

Grey Matter

Arpan R Mehta and others
Brain, Volume 143, Issue 1, January 2020, Pages 374–379, https://doi.org/10.1093/brain/awz367

‘Neuron’ or ‘neurone’? While it is often assumed that these different spellings reflect usage of American versus British English, there are also inconsistencies within these cultural boundaries. Mehta et al. review historical, etymological and linguistic evidence concerning the spelling of ‘neuron(e)’ and conclude that the only correct spelling is ‘neuron’.

Letters to the Editor

Christian Schiemenz and others
Brain, Volume 143, Issue 1, January 2020, Page e1, https://doi.org/10.1093/brain/awz351
Annika Keller and Yvette Zarb
Brain, Volume 143, Issue 1, January 2020, Page e2, https://doi.org/10.1093/brain/awz352
Zuzana Kosutzka and others
Brain, Volume 143, Issue 1, January 2020, Page e3, https://doi.org/10.1093/brain/awz356
Philipp Mahlknecht and others
Brain, Volume 143, Issue 1, January 2020, Page e4, https://doi.org/10.1093/brain/awz357
Dirk Dressler
Brain, Volume 143, Issue 1, January 2020, Page e5, https://doi.org/10.1093/brain/awz366
Judith A Pijpers and others
Brain, Volume 143, Issue 1, January 2020, Page e6, https://doi.org/10.1093/brain/awz368

Corrigendum

Brain, Volume 143, Issue 1, January 2020, Page e7, https://doi.org/10.1093/brain/awz359